Dr. Fehmida Chipty: From GI doc to COO of a digital health startup (Interview)

Dr. Fehmida Chipty: From GI doc to COO of a digital health startup (Interview)

I got to know Dr. Fehmida Chipty because of her involvement in NovoLiver, a fatty liver disease startup I cofounded in US and India. She’s a Boston-based gastroenterologist, and a photographer. As the months rolled by, I observed closely how Fehmida made up her mind to leave private practice GI and take the plunge into the vast unknown. After just a few weeks of exploration, she assumed the role of chief operating officer of NovoLiver transforming the startup’s operations. She brought order to the house.

GI doctors are conditioned to function the way they have for the last 10-15-20-30 years. But the industry is shifting gears. Technology and business forces are disrupting the norm as we know it. Physicians want to change but fear grips them as they do. Most don’t talk about their concerns openly fearing ridicule of their peers.

Watch Dr. Fehmida Chipty’s fascinating narration unfold fundamental issues of gastroenterology. As with Scope Forward interviews, I ask my questions quite directly. Why did she quit GI? What are the problems that we don’t talk about? Why don’t physicians ask for help? What her concerns are with our healthcare system? Is doing colonoscopy after colonoscopy really helping solve for cancer?

Your future self will want you to watch this one.

◘ Why did Dr. Fehmida Chipty quit a thriving GI practice?

◘ Journey from a GI doctor to COO of a digital health startup

◘ What are the unspoken problems faced by GI doctors?

◘ “If the end game is to prevent cancer for a GI, are there more effective ways to do that?“

◘ “Female colonoscopies are more complex”

◘ “Physicians don’t ask for help”

◘  The looming threat of disruptors like AI, digital biology, consolidation, patient mistrust and its effect on physicians

◘ “If Physicians don’t adapt, they won’t survive”

◘ If GIs and physicians leave the field, who will take care of the patients?

◘ “I am scared about where GI and all of medicine is going”

_

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.